Press Releases

Month Year

Month Year

Jun 3, 2006

New Phase III data reports on the safety and efficacy of Risedronate for the treatment of male osteoporosis
Jun 1, 2006

Sanofi-aventis General Meeting of Shareholders
May 30, 2006

New ELOXATIN® and TAXOTERE® data in several tumor types to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO)

430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting's scientific sessions
May 22, 2006

Sanofi-aventis announces steps to protect access to prescription drugs for low income medicare patients

S-A Continues to Advocate for Solutions to Assist Patients Inside the Medicare Part D Benefit - Takes Steps to Ensure Patient Safety
May 16, 2006

Star of the BatmanTM television series leads crusade for baby boomers to recognize importance of Benign Prostatic Hyperplasia (BPH)

Adam West and his wife team up to raise awareness of enlarged prostate due to BPH, the most common prostate problem in men
May 15, 2006

Yolanda King and African-American leaders across the country unite to fight stroke
May 5, 2006

First quarter of 2006: Sales growth of 9.6% on a reported basis and 4.9% on a comparable basis. 52.8% growth in adjusted EPS and 19.8% excluding selected items.
Apr 10, 2006

Appeals court rules in Sanofi-aventis’ favor in the U.S. LOVENOX® (enoxaparin sodium injection) patent infringement case
Mar 23, 2006

TAXOTERE® receives U.S. FDA approval for use in advanced stomach cancer

TAXOTERE(R)-based regimen demonstrates a 23% reduction in the risk of mortality in patients with advanced stomach cancer
Mar 20, 2006

Statement responding to recent media reports regarding appropriate use of AMBIEN® (zolpidem tartrate) CIV in the U.S.

Show per page

Print
Email page
RSS